174 related articles for article (PubMed ID: 35659055)
1. Implicating effector genes at COVID-19 GWAS loci using promoter-focused Capture-C in disease-relevant immune cell types.
Pahl MC; Le Coz C; Su C; Sharma P; Thomas RM; Pippin JA; Cruz Cabrera E; Johnson ME; Leonard ME; Lu S; Chesi A; Sullivan KE; Romberg N; Grant SFA; Wells AD
Genome Biol; 2022 Jun; 23(1):125. PubMed ID: 35659055
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide association studies of COVID-19: Connecting the dots.
Ferreira LC; Gomes CEM; Rodrigues-Neto JF; Jeronimo SMB
Infect Genet Evol; 2022 Dec; 106():105379. PubMed ID: 36280088
[TBL] [Abstract][Full Text] [Related]
3. Genetic association of IL17 and the importance of ABO blood group antigens in saliva to COVID-19.
Nishida N; Sugiyama M; Kawai Y; Naka I; Iwamoto N; Suzuki T; Suzuki M; Miyazato Y; Suzuki S; Izumi S; Hojo M; Tsuchiura T; Ishikawa M; Ohashi J; Ohmagari N; Tokunaga K; Mizokami M
Sci Rep; 2022 Mar; 12(1):3854. PubMed ID: 35264675
[TBL] [Abstract][Full Text] [Related]
4. Integration of risk variants from GWAS with SARS-CoV-2 RNA interactome prioritizes FUBP1 and RAB2A as risk genes for COVID-19.
Shi W; Chen M; Pan T; Chen M; Cheng Y; Hao Y; Chen S; Tang Y
Sci Rep; 2023 Nov; 13(1):19194. PubMed ID: 37932299
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation analyses indicate conserved SARS-CoV-2-host interaction and varied genetic adaptation in immune response factors in modern human evolution.
Lee JW; Lee IH; Sato T; Kong SW; Iimura T
Dev Growth Differ; 2021 Apr; 63(3):219-227. PubMed ID: 33595856
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data.
Hu J; Li C; Wang S; Li T; Zhang H
Hum Genomics; 2021 Feb; 15(1):10. PubMed ID: 33536081
[TBL] [Abstract][Full Text] [Related]
7. Whole-genome sequencing reveals host factors underlying critical COVID-19.
Kousathanas A; Pairo-Castineira E; Rawlik K; Stuckey A; Odhams CA; Walker S; Russell CD; Malinauskas T; Wu Y; Millar J; Shen X; Elliott KS; Griffiths F; Oosthuyzen W; Morrice K; Keating S; Wang B; Rhodes D; Klaric L; Zechner M; Parkinson N; Siddiq A; Goddard P; Donovan S; Maslove D; Nichol A; Semple MG; Zainy T; Maleady-Crowe F; Todd L; Salehi S; Knight J; Elgar G; Chan G; Arumugam P; Patch C; Rendon A; Bentley D; Kingsley C; Kosmicki JA; Horowitz JE; Baras A; Abecasis GR; Ferreira MAR; Justice A; Mirshahi T; Oetjens M; Rader DJ; Ritchie MD; Verma A; Fowler TA; Shankar-Hari M; Summers C; Hinds C; Horby P; Ling L; McAuley D; Montgomery H; Openshaw PJM; Elliott P; Walsh T; Tenesa A; ; ; ; Fawkes A; Murphy L; Rowan K; Ponting CP; Vitart V; Wilson JF; Yang J; Bretherick AD; Scott RH; Hendry SC; Moutsianas L; Law A; Caulfield MJ; Baillie JK
Nature; 2022 Jul; 607(7917):97-103. PubMed ID: 35255492
[TBL] [Abstract][Full Text] [Related]
8. CRISPRi links COVID-19 GWAS loci to LZTFL1 and RAVER1.
Fink-Baldauf IM; Stuart WD; Brewington JJ; Guo M; Maeda Y
EBioMedicine; 2022 Jan; 75():103806. PubMed ID: 34998241
[TBL] [Abstract][Full Text] [Related]
9. Genomic analysis of severe COVID-19 considering or not asthma comorbidity: GWAS insights from the BQC19 cohort.
Amri O; Madore AM; Boucher-Lafleur AM; Laprise C
BMC Genomics; 2024 May; 25(1):482. PubMed ID: 38750426
[TBL] [Abstract][Full Text] [Related]
10. Human Genomics of COVID-19 Pneumonia: Contributions of Rare and Common Variants.
Cobat A; Zhang Q; ; Abel L; Casanova JL; Fellay J
Annu Rev Biomed Data Sci; 2023 Aug; 6():465-486. PubMed ID: 37196358
[TBL] [Abstract][Full Text] [Related]
11. Integrating single-cell sequencing data with GWAS summary statistics reveals CD16+monocytes and memory CD8+T cells involved in severe COVID-19.
Ma Y; Qiu F; Deng C; Li J; Huang Y; Wu Z; Zhou Y; Zhang Y; Xiong Y; Yao Y; Zhong Y; Qu J; Su J
Genome Med; 2022 Feb; 14(1):16. PubMed ID: 35172892
[TBL] [Abstract][Full Text] [Related]
12. Association of CXCR6 with COVID-19 severity: delineating the host genetic factors in transcriptomic regulation.
Dai Y; Wang J; Jeong HH; Chen W; Jia P; Zhao Z
Hum Genet; 2021 Sep; 140(9):1313-1328. PubMed ID: 34155559
[TBL] [Abstract][Full Text] [Related]
13. Host genomics of SARS-CoV-2 infection.
Redin C; Thorball CW; Fellay J
Eur J Hum Genet; 2022 Aug; 30(8):908-914. PubMed ID: 35768520
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
15. Epigenome-wide association study of COVID-19 severity with respiratory failure.
Castro de Moura M; Davalos V; Planas-Serra L; Alvarez-Errico D; Arribas C; Ruiz M; Aguilera-Albesa S; Troya J; Valencia-Ramos J; Vélez-Santamaria V; Rodríguez-Palmero A; Villar-Garcia J; Horcajada JP; Albu S; Casasnovas C; Rull A; Reverte L; Dietl B; Dalmau D; Arranz MJ; Llucià-Carol L; Planas AM; Pérez-Tur J; Fernandez-Cadenas I; Villares P; Tenorio J; Colobran R; Martin-Nalda A; Soler-Palacin P; Vidal F; Pujol A; Esteller M
EBioMedicine; 2021 Apr; 66():103339. PubMed ID: 33867313
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional Profiling and Machine Learning Unveil a Concordant Biosignature of Type I Interferon-Inducible Host Response Across Nasal Swab and Pulmonary Tissue for COVID-19 Diagnosis.
Zhang C; Feng YG; Tam C; Wang N; Feng Y
Front Immunol; 2021; 12():733171. PubMed ID: 34880855
[TBL] [Abstract][Full Text] [Related]
17. First report on genome wide association study in western Indian population reveals host genetic factors for COVID-19 severity and outcome.
Pandit R; Singh I; Ansari A; Raval J; Patel Z; Dixit R; Shah P; Upadhyay K; Chauhan N; Desai K; Shah M; Modi B; Joshi M; Joshi C
Genomics; 2022 Jul; 114(4):110399. PubMed ID: 35680011
[TBL] [Abstract][Full Text] [Related]
18. Progresses on genetic susceptibility of COVID-19.
Yuan-Feng L; Tian-Zhun W; Shun-Qi C; Yu-Ting W; Tao Z; Ruo-Fan L; Gang-Qiao Z
Yi Chuan; 2023 Nov; 45(11):963-975. PubMed ID: 38764262
[TBL] [Abstract][Full Text] [Related]
19. Network-based analysis revealed significant interactions between risk genes of severe COVID-19 and host genes interacted with SARS-CoV-2 proteins.
Qi HX; Shen QD; Zhao HY; Qi GZ; Gao L
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34535795
[TBL] [Abstract][Full Text] [Related]
20. A new insight into sex-specific non-coding RNAs and networks in response to SARS-CoV-2.
Askari N; Hadizadeh M; Rashidifar M
Infect Genet Evol; 2022 Jan; 97():105195. PubMed ID: 34954105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
